NCT04106219 2025-07-23A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaEli Lilly and CompanyPhase 1 Active not recruiting71 enrolled
NCT04239092 2025-07-179-ING-41 in Pediatric Patients With Refractory Malignancies.Actuate Therapeutics Inc.Phase 1 Terminated40 enrolled
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled
NCT04029688 2024-12-20A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid TumorsHoffmann-La RochePhase 1/2 Terminated38 enrolled 34 charts
NCT00960063 2018-08-27A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)Merck Sharp & Dohme LLCPhase 1 Terminated4 enrolled 8 charts